万维提示：
1、投稿方式：在线投稿。
2、官网网址：
https://theunion.org/our-work/journals/ijtld
3、投稿网址：http://mc.manuscriptcentral.com/ijtld
4、官网邮箱：ijtld@theunion.org（编辑部）
5、期刊刊期：月刊，一个月出版一期。
2021年5月6星期四
投稿须知
【官网信息】
INSTRUCTIONS FOR AUTHORS
The International Journal of Tuberculosis and Lung Disease (IJTLD), publishes editorials, original research articles, reviews, letters and correspondence of international significance on tuberculosis and the entire spectrum of lung disease in adults and children. The IJTLD welcomes submissions on basic, translational, clinical, epidemiological and programmatic research relevant to the Union’s mission to find health solutions for the poor, including the development of vaccines, diagnostics and medicines for the prevention, management and control of tuberculosis and other lung diseases.
SUBMISSION OF ARTICLES
Articles should be submitted online via Manuscript Central:
http://mc.manuscriptcentral.com/ijtld.
Before submitting your article, please read and carefully follow the Instructions for Authors outlined below.
All articles must be submitted in English. When necessary, authors are encouraged to seek professional editing service before submission. If the quality of the English is not considered to be adequate, the manuscript will be returned the authors without review.
Authors may be offered the opportunity to re-submit a revised version that has been edited for English language.
Manuscripts may only be actively under consideration by one journal at any given time.
FAST TRACK REVIEW
For exceptional articles of major scientific or public health interest, the Editors-in-Chief may decide to proceed with fast-track review, aiming to reach a first decision within one week. If you believe your article requires fast-track review, please state this in the cover letter of your manuscript along with detailed justification(s).
AUTHORSHIP
The journal recommends the International Committee of Medical Journal Editors’ criteria for authorship (http://www.icmje.org/recommendations/browse/roles-andresponsibilities/defining-the-role-of-authors-and-contributors.html). The ICMJE
recommends that authorship be based on the following four criteria:
1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
When a multicentre group has conducted the study, all individuals who accept direct responsibility for the manuscript should be identified. When submitting a group author manuscript, the corresponding author should clearly identify all individual authors, as well as the group name.
Abstract
An informative structured abstract of not more than 200 words that can be understood without reference to the text should be included. For optimal clarity, the author should use the headings Background, Methods, Results and Conclusion. Abstracts will be translated into French and Spanish on acceptance for publication (authors are welcome to provide their own translations).
Main text headings: Three categories of heading are used.
Major headings (e.g. METHODS, RESULTS) are in Arial 12 bold caps.
Minor heading 1 (e.g. Study population and materials) in Arial 12 italics.
Minor heading 2 (e.g. Human subjects) in Times Roman 12 italics.
Sections should follow the usual conventions Introduction (does not require a heading): This should include the aim, objectives and/or hypotheses for the manuscript, preceded by their rationale.
Methods: This should include a description of the study design, study population, intervention, exposures, outcomes and other relevant variables, where applicable. Details of the statistical analysis plan and sample size and study power should also be included.
Methods should be described in a manner that is conducive to replication.
Details of ethics approval (or a statement as to why it was not required) should be provided in the Methods section of all research studies. All studies involving human subjects should include details of informed consent.
……
